Brief: Evolent Health Q2 Revenue USD 469.136 Million Vs. IBES Estimate USD 460.7 Million
02/08/2023 21:10
Aug 02 (Reuters) - Evolent Health Q2 operating income USD -21.568 million. * Q2 net income USD -41.411 million * Q2 adjusted EBITDA USD 47.4 million * Q2 adjusted EBITDA margin 10.1% * Outlook Q3 Adjusted EBITDA USD 42-47 Million
Recent news on Evolent Health
See all newsEvolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary
Evolent Health Q2 revenue beats expectations
Brief: Evolent Health Q2 Revenue USD 652.52 Million Vs. IBES Estimate USD 598 Million
Evolent Health, Inc. expected to post a loss of 2 cents a share - Earnings Preview
Evolent Health Q1 revenue misses estimates as margin narrows